Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
Journal of the National Cancer Institute
|
September 18, 2015
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval
Denis L Jardim, Denis L Fontes Jardim, Maria Schwaederle, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 16, 2012
Proton beam therapy and concurrent chemotherapy for esophageal cancer
Steven H Lin, Ritsuko Komaki, Zhongxing Liao, et al.
Obstetrics and Gynecology
|
September 23, 2010
Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery
Alpa M Nick, Kathleen M Schmeler, Michael M Frumovitz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 13, 2013
Predictors of postoperative complications after trimodality therapy for esophageal cancer
Jingya Wang, Caimiao Wei, Susan L Tucker, et al.
The Journal of Urology
|
November 17, 2007
Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer
Wassim Kassouf, Peter C Black, Tomasz Tuziak, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
November 2, 2013
FXR silencing in human colon cancer by DNA methylation and KRAS signaling
Ann M Bailey, Le Zhan, Dipen Maru, et al.
Plos One
|
August 29, 2015
Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers
Yan Zhang, Aleksandra Nowicka, Travis N Solley, et al.
Endocrine-Related Cancer
|
April 23, 2015
Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors
Arvind Dasari, Alexandria Phan, Sanjay Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2016
TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis
Zahi Mitri, Rita Nanda, Kimberly Blackwell, et al.
Oncotarget
|
December 17, 2014
Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380
Xiao Huang, Mengru Cao, Li Wang, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
Journal of the National Cancer Institute
|
September 18, 2015
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval
Denis L Jardim, Denis L Fontes Jardim, Maria Schwaederle, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 16, 2012
Proton beam therapy and concurrent chemotherapy for esophageal cancer
Steven H Lin, Ritsuko Komaki, Zhongxing Liao, et al.
Obstetrics and Gynecology
|
September 23, 2010
Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery
Alpa M Nick, Kathleen M Schmeler, Michael M Frumovitz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 13, 2013
Predictors of postoperative complications after trimodality therapy for esophageal cancer
Jingya Wang, Caimiao Wei, Susan L Tucker, et al.
The Journal of Urology
|
November 17, 2007
Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer
Wassim Kassouf, Peter C Black, Tomasz Tuziak, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
November 2, 2013
FXR silencing in human colon cancer by DNA methylation and KRAS signaling
Ann M Bailey, Le Zhan, Dipen Maru, et al.
Plos One
|
August 29, 2015
Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers
Yan Zhang, Aleksandra Nowicka, Travis N Solley, et al.
Endocrine-Related Cancer
|
April 23, 2015
Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors
Arvind Dasari, Alexandria Phan, Sanjay Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2016
TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis
Zahi Mitri, Rita Nanda, Kimberly Blackwell, et al.
Oncotarget
|
December 17, 2014
Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380
Xiao Huang, Mengru Cao, Li Wang, et al.
Page
of 7